The tradipitant therapy is being studied to explore if the administration prevents or treats the cytokine storm and acute respiratory distress syndrome leading to respiratory failure and high mortality in affected patients with COVID-19.
Adults aged 18-90 with confirmed laboratory COVID-19 infection and hospitalized for treatment.
Detailed Eligibility: Patients participating in other clinical trials are excluded
III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
Memorial Hospital Central
Memorial Hospital North
Protocol Number: 20-6506
More information available at ClinicalTrials.gov: NCT04326426
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers